Study using melanoma-specific microsystems – melanoma-specific OncoBean platform in combination with melanoma-specific antibodies to isolate circulating tumor cells , diagnose melanoma and evaluate the effectiveness of surgical resection.
The effectiveness of the advanced test
The test can not only be used to diagnosis of malignancy but also to evaluate see all Cancer cells were successfully removed after surgery for skin cancer. Advanced testing may soon rule out invasive skin biopsies to detect skin cancer.
“This is the first comprehensive study of circulating tumor cells — or CTCs — to evaluate the effectiveness of surgery using microfluidic systems in melanoma, including changes in CTC counts. , CTC cluster configuration and gene expression construct,” first author, Yoon-Tae Kang, Ph.
“CTCs have the ability to accurately identify treatment resistance and relapse, and may be a valuable biomarker for non-invasive monitoring of disease progression.” says corresponding author Sunitha Nagrath, Ph.
Source: Medindia
